UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Deconjugation of Nedd8 from Cul1 Is Directly Regulated by Skp1-F-box and Substrate, and the COP9 Signalosome Inhibits Deneddylated SCF by a Noncatalytic Mechanism

The Journal of biological chemistry, 2012-08, Vol.287 (35), p.29679-29689

2012

Volltextzugriff (PDF)

The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma

PloS one, 2021-11, Vol.16 (11), p.e0259241-e0259241

2021

Volltextzugriff (PDF)

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment

Journal for immunotherapy of cancer, 2017-12, Vol.5 (1), p.101-101, Article 101

2017

Volltextzugriff (PDF)

Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer

Cell reports (Cambridge), 2017-01, Vol.18 (3), p.601-610

2017

Volltextzugriff (PDF)

Control of cullin-ring ubiquitin ligase activity by nedd8

Sub-cellular biochemistry, 2010, Vol.54, p.41

2010

Volltextzugriff (PDF)

S100A7 and the progression of breast cancer

Breast cancer research : BCR, 2004-01, Vol.6 (4), p.153-159, Article 153

2004

Volltextzugriff (PDF)

S100 proteins and their influence on pro-survival pathways in cancer

Biochemistry and cell biology, 2004-08, Vol.82 (4), p.508-515

2004

Volltextzugriff (PDF)

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer

Cancer research (Chicago, Ill.), 2005-07, Vol.65 (13), p.5696-5702

2005

Volltextzugriff (PDF)

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (22), p.10265-10272

2005

Volltextzugriff (PDF)

Psoriasin (S100A7) Expression Is Associated with Poor Outcome in Estrogen Receptor-negative Invasive Breast Cancer

Clinical cancer research, 2003-07, Vol.9 (7), p.2627-2631

2003

Volltextzugriff (PDF)

Necrosis and hypoxia in invasive breast carcinoma

Breast cancer research and treatment, 2003-09, Vol.81 (1), p.61-69

2003

Volltextzugriff (PDF)

Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis

BMC cancer, 2005-02, Vol.5 (1), p.17-17, Article 17

2005

Volltextzugriff (PDF)

RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer

BMC cancer, 2002-11, Vol.2 (1), p.28-28, Article 28

2002

Volltextzugriff (PDF)

Psoriasin interacts with Jab1 and influences breast cancer progression

Cancer research (Chicago, Ill.), 2003-04, Vol.63 (8), p.1954-1961

2003

Volltextzugriff (PDF)

S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situof the breast

Breast cancer research : BCR, 2004-04, Vol.6 (4), Article R308

2004

Volltextzugriff (PDF)

S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast

Breast cancer research : BCR, 2004, Vol.6 (4), p.R308-R315

2004

Volltextzugriff (PDF)

Analysis of Gene Expression in Ductal Carcinoma in Situ of the Breast

Clinical cancer research, 2002-12, Vol.8 (12), p.3788-3795

2002

Volltextzugriff (PDF)

Identification of new human coding steroid receptor RNA activator isoforms

Biochemical and biophysical research communications, 2003-02, Vol.301 (2), p.509-515

2003

Volltextzugriff (PDF)

Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer

Clinical cancer research, 2018-12, Vol.24 (24), p.6433-6446

2018

Volltextzugriff (PDF)

Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity

Journal of medicinal chemistry, 2023-01, Vol.66 (1), p.345-370

2023

Volltextzugriff (PDF)

Abstract 3509: The glutaminase inhibitor CB-839 synergizes with CDK4/6 and PARP inhibitors in pre-clinical tumor models

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3509-3509

2018

Volltextzugriff (PDF)

Abstract 4134: Reversal of adenosine-mediated immune suppression by CB-708, an orally bioavailable and potent small molecule inhibitor of CD73

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4134-4134

2019

Volltextzugriff (PDF)

Abstract 4711: CB-839, a selective glutaminase inhibitor, synergizes with signal transduction pathway inhibitors to enhance anti-tumor activity

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4711-4711

2015

Volltextzugriff (PDF)

Abstract 552: Immuno-oncology agent CB-1158 is a potent and selective arginase inhibitor and causes an immune-mediated anti-tumor response

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.552-552

2016

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(37)
Dissertationen
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Deconjugation of Nedd8 from Cul1 Is Directly Regulated by Skp1-F-box and Substrate, and the COP9 Signalosome Inhibits Deneddylated SCF by a Noncatalytic Mechanism

The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment

Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer

Control of cullin-ring ubiquitin ligase activity by nedd8

S100A7 and the progression of breast cancer

S100 proteins and their influence on pro-survival pathways in cancer

The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene

Psoriasin (S100A7) Expression Is Associated with Poor Outcome in Estrogen Receptor-negative Invasive Breast Cancer

Necrosis and hypoxia in invasive breast carcinoma

Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis

RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer

Psoriasin interacts with Jab1 and influences breast cancer progression

S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situof the breast

S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast

Analysis of Gene Expression in Ductal Carcinoma in Situ of the Breast

Identification of new human coding steroid receptor RNA activator isoforms

Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer

ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies

Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity

Abstract 3509: The glutaminase inhibitor CB-839 synergizes with CDK4/6 and PARP inhibitors in pre-clinical tumor models

Abstract 4134: Reversal of adenosine-mediated immune suppression by CB-708, an orally bioavailable and potent small molecule inhibitor of CD73

Abstract 4711: CB-839, a selective glutaminase inhibitor, synergizes with signal transduction pathway inhibitors to enhance anti-tumor activity

Abstract 552: Immuno-oncology agent CB-1158 is a potent and selective arginase inhibitor and causes an immune-mediated anti-tumor response

Suchergebnisse filtern